Astrana Health, Inc (ASTH) insider trading
Every open-market stock purchase and sale by Astrana Health, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ASTH insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 27, 2026 | Brandon Sim (CEO) | Sold (not open market) | $48.6K |
| Jun 10, 2026 | Linda Dong (Director) | Bought (not open market) | — |
| Jun 10, 2026 | John Chiang (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Weili Dai (Director) | Bought (not open market) | — |
| Jun 10, 2026 | David Schmidt (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Matthew Mazdyasni (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Mitchell W Kitayama (Director) | Bought (not open market) | — |
| May 16, 2026 | Chandan Basho (CFO) | Sold (not open market) | $312K |
| Apr 14, 2026 | Chandan Basho (CFO) | Sold (not open market) | $113K |
| Apr 6, 2026 | Brandon Sim (CEO) | Bought (not open market) | — |
| Apr 6, 2026 | Thomas S. Lam (Director) | Bought (not open market) | — |
| Apr 6, 2026 | Kenneth T. Sim (Chair) | Bought (not open market) | — |
| Apr 2, 2026 | Chandan Basho (CFO) | Sold (not open market) | $52.4K |
| Apr 1, 2026 | Dinesh M. Kumar (C-suite exec) | Sold (not open market) | $1.4M |
| Apr 1, 2026 | Dinesh M. Kumar (C-suite exec) | Bought (not open market) | — |
| Mar 26, 2026 | Glenn Sobotka (C-suite exec) | Sold (not open market) | $16.1K |
| Mar 5, 2026 | Thomas S. Lam (Director) | Sold (not open market) | $232K |
| Mar 5, 2026 | Dinesh M. Kumar (C-suite exec) | Sold (not open market) | $42.5K |
| Mar 5, 2026 | Chandan Basho (CFO) | Sold (not open market) | $31.1K |
| Feb 2, 2026 | Brandon Sim (CEO) | Bought (not open market) | — |
| Jan 23, 2026 | Dinesh M. Kumar (C-suite exec) | Sold (not open market) | $292K |
| Jan 13, 2026 | David Schmidt (Director) | Sold (not open market) | $116K |
| Jan 13, 2026 | David Schmidt (Director) | Bought (not open market) | — |
| Jan 1, 2026 | Dinesh M. Kumar (C-suite exec) | Sold (not open market) | $127K |
| Dec 8, 2025 | Thomas S. Lam (Director) | Sold (not open market) | $569K |
Who's trading ASTH
- Brandon Sim, CEO: other filings, last Jun 27, 2026
- John Chiang, Director: other filings, last Jun 10, 2026
- Weili Dai, Director: other filings, last Jun 10, 2026
- Linda Dong, Director: other filings, last Jun 10, 2026
- Matthew Mazdyasni, Director: other filings, last Jun 10, 2026
- Mitchell W Kitayama, Director: other filings, last Jun 10, 2026
- David Schmidt, Director: other filings, last Jun 10, 2026
- Chandan Basho, CFO: other filings, last May 16, 2026
- Kenneth T. Sim, Chair: other filings, last Apr 6, 2026
- Thomas S. Lam, Director: other filings, last Apr 6, 2026
- Dinesh M. Kumar, C-suite exec: other filings, last Apr 1, 2026
- Glenn Sobotka, C-suite exec: other filings, last Mar 26, 2026
- Linda Marsh, Director: other filings, last Nov 3, 2025
Get free alerts when an insider at Astrana Health, Inc files a new trade →